Welcome

New Pathways to Solve Worldwide Health and Wellness Challenges

The world is always changing. Nowhere is this clearer than in the evolving needs of the global healthcare community. Drug discovery and commercialization must adapt to keep up. New challenges such as swine flu cry for attention while the impact of age-old problems such as hypertension and diabetes grow and spread.

Caleco Pharma Corporation is dedicated to meeting these challenges in two fundamental ways.

First we strive to identify and develop unique biopharmaceutical products that represent important new therapeutic advances and can broadly impact public health.  At the same time we provide innovative healthcare professional and consumer education programs that increase clinical knowledge and support the use of our products in the marketplace. This will ensure that our products reach their maximum clinical and commercial value as rapidly as possible.

FORWARD-LOOKING STATEMENTS

In our website, certain materials include forward-looking statements within the meaning of section 27a of the securities act of 1933 (as amended) and section 21e of the securities exchange act of 1934 (as amended). All statements other than statements of historical facts, are forward-looking statements that are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined, and assumptions of management. Forward looking statements are generally, but not always, identified by the words “plan,” “anticipate,” “believe,” “estimate,” ”should,” ”expect” and similar expressions include our expectations and objectives regarding our future financial position, operating results and business strategy. There are no assurances that the United States Patents and Trademarks Office will grant Caleco Pharma Corp. (”Caleco”) a patent in connection with its current patent applications. In addition, there are no assurances that Caleco will be able to manufacture and produce its products; that its products will be effective; or it will be able to carry out any pre-clinical or clinical trials of its products. Caleco’s ability to implement its business plan is subject to its ability to obtain substantial financing, of which there are no assurances. Readers are cautioned not to place undue reliance on the forward-looking statements made in our website.